Hospital Centralized Monitoring of Post-market Clinical Safety of Guipi Mixture

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2024000037

Enrollment

Unknown

Registered

2024-03-29

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorders

Interventions

Guipi admixture treatment group:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the indications in the instructions of Guipi Mixture or according to the patient's condition, the clinician judges that the application of Guipi mixture is suitable, and the doctor has issued a prescription for it; 2. Patients who voluntarily participate and sign informed consent; 3. Willing to cooperate with at least one follow-up visit.

Exclusion criteria

Exclusion criteria: Patients judged by the investigator to be unable to complete or unfit to participate in the study.

Design outcomes

Primary

Measure	Time frame
Adverse drug events/ Adverse drug reactions;	—

Countries

China

Contacts

Public ContactXuechang Wang

Anning First People's Hospital

ynwangxc@163.com+86 138 8831 6597

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026